A look at the weighted underlying holdings of the First Trust Consumer Staples AlphaDEX Fund (Symbol: FXG) shows an impressive 11.9% of holdings on a weighted basis have experienced insider buying within the past six months.
CVS Health Corporation (Symbol: CVS), which makes up 3.23% of the First Trust Consumer Staples AlphaDEX Fund (Symbol: FXG), has seen 2 directors and officers purchase shares in the past six months, according to the recent Form 4 data. The ETF holds a total of $9,771,788 worth of CVS, making it the #11 largest holding. The table below details the recent insider buying activity observed at CVS:
CVS — last trade: $64.26 — Recent Insider Buys:
| Purchased | Insider | Title | Shares | Price/Share | Value |
|---|---|---|---|---|---|
| 02/18/2025 | Michael F. Mahoney | Director | 30,000 | $66.70 | $2,001,000 |
| 06/05/2025 | Guy P. Sansone | Director | 1,570 | $63.70 | $100,009 |
And Reynolds Consumer Products Inc (Symbol: REYN), the #12 largest holding among components of the First Trust Consumer Staples AlphaDEX Fund (Symbol: FXG), shows 2 directors and officers as recently filing Form 4's indicating purchases. The ETF holds $9,498,378 worth of REYN, which represents approximately 3.14% of the ETF's total assets at last check. The recent insider buying activity observed at REYN is detailed in the table below:
REYN — last trade: $21.92 — Recent Insider Buys:
| Purchased | Insider | Title | Shares | Price/Share | Value |
|---|---|---|---|---|---|
| 12/19/2024 | Rolf Stangl | Director | 3,682 | $27.50 | $101,255 |
| 02/10/2025 | Rolf Stangl | Director | 6,000 | $24.89 | $149,313 |
| 05/06/2025 | Rolf Stangl | Director | 2,500 | $23.22 | $58,050 |
| 05/07/2025 | Rolf Stangl | Director | 2,500 | $22.75 | $56,875 |
| 05/30/2025 | Chris Mayrhofer | VP, Controller & CAO | 23,266 | $22.11 | $514,319 |
| 06/06/2025 | Rolf Stangl | Director | 4,500 | $21.70 | $97,650 |
10 ETFs With Stocks That Insiders Are Buying »
Also see:
UVSP market cap history
Top Ten Hedge Funds Holding RAIL
Funds Holding ISAA
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
